Clinical Utility and Validation of the Krakow DCM Risk Score-A Prognostic Model Dedicated to Dilated Cardiomyopathy.

Ewa Dziewięcka Mateusz WiniarczykSylwia Wiśniowska-ŚmiałekAleksandra Karabinowska-MałochaMatylda GliniakJan RobakMonika Kaciczak Przemyslaw LeszekMałgorzata Celińska-SpodarMarcin DziewięckiPawel P Rubis

Published in: Journal of personalized medicine (2022)

The Krakow DCM Risk Score was found to have good predictive accuracy. The 2-year mortality risk > 6% has good discrimination for the identification of high-risk patients and can be applied in everyday practice.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
primary care
prognostic factors
quality improvement